We note the consistent relationship between a higher MDS with increased risks of outcomes known to be associated with low magnesium intake and/or status, such as CVD and hypertension, CKD and impaired kidney function, diabetes and glucose–insulin dynamics, and related biomarkers. This evidence concerns the gene INS and Hypertension.